Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
In the GenAI era, program comprehension is not just another skill in the toolbox; it is the toolbox itself. It enables learners to move beyond passive acceptance of AI outputs, guiding them to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback